SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kerkar N, Hadziz N, Davies ET, Portmann B, Donaldson PT, Rela M, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998: 351; 409413.
  • 2
    Hernandez HZ, Kovarik P, Whitington PF, Alomso EM. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastoenterol Nutr 2001; 32: 131136.
  • 3
    Spada M, Bertani A, Sonzogni A, Petz W, Riva S, Torre G, et al. A cause of late dysfunction after liver transplantation in children: De-novo autoimmune hepatitis. Transplant Proc 2001; 33: 17471748.
  • 4
    Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathological staging and reporting of chronic rejection. Hepatology 2000; 31: 792799.
  • 5
    Gouw AS, van den Heuvel MC, van de Berg AP, Slooff MJ, de Jong KP, Poppema S. The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection. Transplantation, 2002: 73: 243247.
  • 6
    D'Antiga L, Dhawan A, Portmann B, Francavilla R, Rela M, Heaton N, et al. Late cellular rejection in paediatric liver transplantation: Aetiology and outcome. Transplantation 2002: 73: 8084.
  • 7
    Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004; 40: 37.
  • 8
    Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998: 65; 10721075.
  • 9
    Andreis S, Casamayou L, Sempoux C, Burlet M, Reding R, Bernard Otte J, et al. Posttransplant immune hepatitis in pediatric liver transplant recipient: Incidence and maintenance therapy with azathioprine. Transplantation 2001: 72; 267272.